Holen Sie sich die Stockscreener-App
112.50
0.12%
0.13
Handel nachbörslich:
108.79
-3.71
-3.30%
Schlusskurs vom Vortag:
$112.37
Offen:
$111.86
24-Stunden-Volumen:
1.14M
Relative Volume:
0.68
Marktkapitalisierung:
$22.37B
Einnahmen:
$7.60B
Nettoeinkommen (Verlust:
$1.08B
KGV:
21.39
EPS:
5.26
Netto-Cashflow:
$1.26B
1W Leistung:
+1.68%
1M Leistung:
+7.84%
6M Leistung:
+6.44%
1J Leistung:
-12.43%
1-Tages-Spanne:
$110.85
$112.97
1-Wochen-Bereich:
$110.44
$113.64
52-Wochen-Spanne:
$97.69
$130.89
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
112.50 | 22.37B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Evercore ISI Adjusts Zimmer Biomet Holdings' Price Target to $116 From 110, Maintains In Line Rating - MarketScreener
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Purchased by UniSuper Management Pty Ltd - MarketBeat
Zimmer Biomet granted CE Mark for RibFix Advantage Fixation System - MSN
Zimmer Biomet Gets CE Mark Approval for RibFix Advantage Fixation System - MarketScreener
Zimmer Biomet wins CE Mark for RibFix Advantage (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet wins CE mark for rib fixation system - MassDevice
Zimmer Biomet Receives CE Mark Approval For Ribfix Advantage® Fixation System - MarketScreener
Groundbreaking Rib Fixation Technology Gets Historic European ApprovalZimmer Biomet Leads Innovation - Stock Titan
Corebridge Financial Inc. Has $5.03 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Providence Capital Advisors LLC Buys 2,800 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings (NYSE:ZBH) Might Have The Makings Of A Multi-Bagger - Yahoo Finance
Zimmer Biomet Stock Price | ZBH Stock Quote, News, and History - markets.businessinsider.com
Just Three Days Till Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Will Be Trading Ex-Dividend - simplywall.st
Ex-Dividend Reminder: PG&E, Zimmer Biomet Holdings and Ensign Group - Nasdaq
Goldman Sachs Adjusts PT on Zimmer Biomet Holdings to $120 From $115, Maintains Neutral Rating - MarketScreener
Looking Into Zimmer Biomet Holdings's Recent Short Interest - Benzinga
3 Promising Surgical Robotics Stocks to Keep an Eye on in 2025 - TradingView
Zimmer Holdings Q3 profit surges, cuts FY08 outlookupdate - RTTNews
Europe Viscosupplementation Market Set to Witness Significant - openPR
Is Zimmer Biomet Stock Outperforming the S&P 500? - MSN
Reflecting On Surgical Equipment & ConsumablesDiversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH) - Yahoo Finance
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec – Ortho Spine News - OrthoSpineNews
Spinal Fusion Device Market Forecast Report and Company - GlobeNewswire
Zimmer Biomet Holdings (NYSE:ZBH) Has Announced A Dividend Of $0.24 - Simply Wall St
Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24 - Yahoo
Zimmer Biomet Focuses on Innovation Amid Growing Competition - Yahoo Finance
Zimmer Biomet at Barclays Conference: Strategic Growth Insights By Investing.com - Investing.com South Africa
Proficio Capital Partners LLC Takes $55,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Rep. Julie Johnson Sells Off Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Zimmer Biomet at Barclays Conference: Strategic Growth Insights - Investing.com
Zimmer Q3 Sales Disappoint, Trims FY10 Sales Growth ForecastUpdate - RTTNews
Q3 EPS Estimates for Zimmer Biomet Lowered by Zacks Research - Defense World
Zimmer Biomet Focusing On Innovation Pipeline And Product Portfolio To Drive Growth - RTTNews
ZBH Stock to Gain From Global Expansion Amid Difficult FX Scenario - TradingView
Zimmer Biomet Holdings: Balancing Optimism with Caution Amid Strategic Growth and Market Challenges - TipRanks
Zimmer Biomet Holdings: Strategic Initiatives and Execution Risks Justify Hold Rating - TipRanks
Zimmer Biomet Q1 EPS Forecast Reduced by Zacks Research - Defense World
Paragon 28 clears regulatory hurdle in Zimmer Biomet merger By Investing.com - Investing.com Australia
Paragon 28 clears regulatory hurdle in Zimmer Biomet merger - Investing.com India
Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act - Joplin Globe
Paragon 28 Acquisition by Zimmer Biomet Clears Major Regulatory Hurdle - StockTitan
Tissue Engineering Market Analysis, Competitive Intelligence, and Growth Opportunities to 2030Zimmer Biomet, Stryker Corporation, and 3D BioFibR Lead the Industry - GlobeNewswire
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Holdings Lowered by Steward Partners Investment Advisory LLC - Defense World
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting - PR Newswire
Zimmer Biomet Launches New Hip, Knee Systems and AI Solutions at AAOS - Stock Titan
Zimmer Biomet Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Mutual of America Capital Management LLC Decreases Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Zimmer Biomet SVP Lori Winkler sells $150,649 in stock By Investing.com - Investing.com Canada
Top Executive Cashes In on Zimmer Biomet Holdings Stock - TipRanks
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference - GuruFocus.com
Zimmer Biomet SVP Lori Winkler sells $150,649 in stock - Investing.com
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.82%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):